These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumab. Maloney AK; Giobbie-Hurder A; Katukota N; Fogarasi MC; Ott PA; Hodi FS; Sussman TA; Silk AW; Haq R; Liu D; Insco M; Buchbinder EI J Immunother Cancer; 2024 Aug; 12(8):. PubMed ID: 39209453 [TBL] [Abstract] [Full Text] [Related]
7. Effect of Chahla C; Rima M; Mouawad C; Roufayel R; Kovacic H; El Obeid D; Sabatier JM; Luis J; Fajloun Z; El-Waly B Molecules; 2024 Aug; 29(16):. PubMed ID: 39203027 [TBL] [Abstract] [Full Text] [Related]
8. Decursin ameliorates neurotoxicity induced by glutamate through restraining ferroptosis by up-regulating FTH1 in SH-SY5Y neuroblastoma cells. Chen Z; Wang F; Chen Z; Zheng N; Zhou Q; Xie L; Sun Q; Li L; Li B Neuroscience; 2024 Nov; 559():139-149. PubMed ID: 39197742 [TBL] [Abstract] [Full Text] [Related]
9. Antiproliferative effects of LY-2183240 combined with various chemotherapeutic drugs in an isobolographic in vitro model of malignant melanoma. Marzęda P; Wróblewska-Łuczka P; Florek-Łuszczki M; Góralczyk A; Łuszczki JJ Eur J Pharmacol; 2024 Nov; 982():176937. PubMed ID: 39187040 [TBL] [Abstract] [Full Text] [Related]
10. Terphenyllin induces CASP3-dependent apoptosis and pyroptosis in A375 cells through upregulation of p53. Wu W; Wu MY; Dai T; Ke LN; Shi Y; Hu J; Wang Q Cell Commun Signal; 2024 Aug; 22(1):409. PubMed ID: 39169379 [TBL] [Abstract] [Full Text] [Related]
11. Methylglyoxal induces death in human brain neuronal cells (SH-SY5Y), prevented by metformin and dapagliflozin. Victor-Sami S; Kamali-Roosta A; Shamsaldeen YA J Diabetes Complications; 2024 Sep; 38(9):108832. PubMed ID: 39116474 [TBL] [Abstract] [Full Text] [Related]
13. Feasibility and Impact of Embedding an Extended DNA and RNA Tissue-Based Sequencing Panel for the Routine Care of Patients with Advanced Melanoma in Spain. Castrejon N; Martin R; Carrasco A; Castillo P; Garcia A; Albero-González R; García M; Marginet M; Palau N; Hernández M; Montironi C; Clot G; Arance A; Alos L; Teixido C Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000050 [TBL] [Abstract] [Full Text] [Related]
14. Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children. Schoettler ML; Ofori J; Bryson E; Spencer K; Qayed M; Stenger E; Bidgoli A; Chonat S; Westbrook A; Williams KM Transplant Cell Ther; 2024 Sep; 30(9):929.e1-929.e6. PubMed ID: 38936547 [TBL] [Abstract] [Full Text] [Related]
15. Assessment of Molecular Markers in Pediatric Ovarian tumors: Romanian Single-Center Experience. Bîcă O; Ciongradi CI; Benchia D; Sârbu I; Alecsa M; Cristofor AE; Bîcă DE; Lozneanu L Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928458 [TBL] [Abstract] [Full Text] [Related]
16. Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade. Mengoni M; Braun AD; Hinnerichs MS; Aghayev A; Tüting T; Surov A J Cancer Res Clin Oncol; 2024 May; 150(5):275. PubMed ID: 38796605 [TBL] [Abstract] [Full Text] [Related]
18. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma. Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213 [TBL] [Abstract] [Full Text] [Related]
19. Linking pesticide exposure to neurodegenerative diseases: An in vitro investigation with human neuroblastoma cells. Alehashem M; Alcaraz AJ; Hogan N; Weber L; Siciliano SD; Hecker M Sci Total Environ; 2024 Jul; 933():173041. PubMed ID: 38723972 [TBL] [Abstract] [Full Text] [Related]
20. [Advanced melanoma with low-burden and low-risk disease: a clinical case.]. Bersanelli M Recenti Prog Med; 2024 May; 115(5):7e-12e. PubMed ID: 38708540 [TBL] [Abstract] [Full Text] [Related] [Next]